Evidence map›Paper›PMID 34948278›Full record

ArticleInternational journal of molecular sciences2021

Stimulation of Sulfonamides Antibacterial Drugs Activity as a Result of Complexation with Ru(III): Physicochemical and Biological Study.

Paulina Spisz, Agnieszka Chylewska, Aleksandra Królicka, Sandra Ramotowska, Aleksandra Dąbrowska, Mariusz Makowski

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. ACS omega · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paulina SpiszFaculty of Chemistry, University of Gdańsk, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland.
Agnieszka ChylewskaFaculty of Chemistry, University of Gdańsk, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland.ORCID 0000-0001-7413-1503
Aleksandra KrólickaIntercollegiate Faculty of Biotechnology of UG & MUG, University of Gdańsk, ul. Abrahama 58, 80-307 Gdańsk, Poland.ORCID 0000-0001-5231-283X
Sandra RamotowskaFaculty of Chemistry, University of Gdańsk, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland.
Aleksandra DąbrowskaFaculty of Chemistry, University of Gdańsk, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland.
Mariusz MakowskiFaculty of Chemistry, University of Gdańsk, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland.ORCID 0000-0002-7342-722X

Funding

National Science Center UMO-2019/33/B/ST4/00031
6 · The paper itself

Abstract

Antibiotic resistance is a global problem, and one promising solution to overcome this issue is using metallodrugs, which are drugs containing metal ions and ligands. These complexes are superior to free ligands in various characteristics including anticancer properties and mechanism of action. The pharmacological potential of metallodrugs can be modulated by the appropriate selection of ligands and metal ions. A good example of proper coordination is the combination of sulfonamides (sulfamerazine, sulfathiazole) with a ruthenium(III) ion. This work aimed to confirm that the activity of sulfonamides antibacterial drugs is initiated and/or stimulated by their coordination to an Ru(III) ion. The study determined the structure, electrochemical profile,

Indexed as

Anti-Bacterial AgentsCoordination ComplexesDNAElectrochemistryLigandsMolecular StructureRutheniumSpectrometry, FluorescenceSulfonamidesAnti-Bacterial AgentsCoordination ComplexesDNALigandsRutheniumSulfonamidesanticancer propertiesantimicrobial propertiesCT-DNA affinityelectrochemical profilemetallodrugsRu(III) complexessulfamerazinesulfathiazolesulfonamides

Identifiers

PMID34948278
PMCPMC8708937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.